JPMORGAN CHASE & CO - 31 Dec 2025 SCHEDULE 13G Report for LB Pharmaceuticals Inc Common Stock, $0.0001 par value (LBRX)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: LB Pharmaceuticals Inc Common Stock, $0.0001 par value
Symbol: LBRX
Shares outstanding: 25,579,079 shares
Disclosed Ownership: 1,611,482 shares
Ownership: 6.3%
Form type: SCHEDULE 13G
Filing time: 21 Jan 2026, 08:13:39 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	6.3%	1,611,482	1,471,295	0	Rachel Tsvaygoft	Vice President